Innoviva
Innoviva is committed to building long-lasting value and improving patient care.
Business Model:
Revenue: $373.2M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Innoviva Information
Geographic Data
Address: 1350 Old Bayshore Hwy
City: Burlingame
State: CA
Zip: 94010
Country: US
Financial Info
Stage:
Raised Last:
$225M
Raised Total:$193M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Innoviva is committed to building long-lasting value and improving patient care, by partnering with companies that advance innovative therapies. Anchored by its respiratory assets, Innoviva blends a unique fusion of operational industry expertise and financial insight to create a solid foundation for capital returns—and carve a path towards a healthier world for patients.
Contact Phone:
+16502389600
Contact Email:
Innoviva went public on 10/8/2004 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/8/2004
Ticker Symbol:
INVA
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2022 | Nanolive | Series C | 2.2M |
| 10/2022 | Gate Neurosciences | Venture Round | 25M |
| 1/2023 | Armata Pharmaceuticals | Post-IPO Debt | 30M |
| 10/2020 | InCarda Therapeutics | Series C | 30M |
| 10/2021 | Armata Pharmaceuticals | Post-IPO Equity | 7M |
| 2/2022 | Armata Pharmaceuticals | Post-IPO Equity | 45M |
| 2/2022 | Armata Pharmaceuticals | Post-IPO Equity | 0 |
| 10/2021 | Armata Pharmaceuticals | Post-IPO Equity | 0 |
| 10/2020 | InCarda Therapeutics | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
